IDEXX Laboratories Analyst Price Targets

PRO

¿Por qué se mueve?:IDEXX Laboratories shares are trading higher after the company reported bet...

Ganancias: Los beneficios de Q3 2026 se publicaron el lun nov 2nd, antes de la apertura del mercado

Conferencia telefónica: La conferencia telefónica más reciente comenzó a las 8:30 a. m., hace 1 día

Wall Street analyst price targets and consensus rating for IDEXX Laboratories (IDXX).

Price Target Range — 13 Quarters

Analyst Consensus — 11 Analysts

7Buy

4Hold

Consensus RatingNeutral# Analysts11Avg. Consensus PT$665Upside to Avg. PT-0.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 3, 2026	Morgan Stanley	Erin Wright	PT Raise	Overweight	$805→$810
Nov 3, 2026	UBS	Andrea Alfonso	PT Raise	Neutral	$627→$700
Oct 30, 2026	BTIG	Mark Massaro	Suspends	Buy	—
Oct 27, 2026	UBS	Andrea Alfonso	PT Cut	Neutral	$670→$627
Oct 16, 2026	JP Morgan	Chris Schott	PT Cut	Overweight	$775→$750
Oct 12, 2026	Keybanc	Steve Dechert	Initiate	Sector Weight	—
Aug 11, 2026	Barclays	Glen Santangelo	PT Cut	Overweight	$800→$710
Aug 5, 2026	UBS	Andrea Alfonso	PT Raise	Neutral	$620→$670
Aug 5, 2026	Citigroup	Daniel Grosslight	PT Raise	Neutral	$650→$670
Jul 27, 2026	UBS	Andrea Alfonso	PT Cut	Neutral	$640→$620
Apr 28, 2026	UBS	Andrea Alfonso	PT Cut	Neutral	$730→$640
Apr 15, 2026	Citigroup	Daniel Grosslight	Initiate	Neutral	$650
Mar 31, 2026	Stifel	Jonathan Block	PT Cut	Buy	$775→$675
Feb 9, 2026	Piper Sandler	David Westenberg	PT Cut	Neutral	$775→$750
Feb 5, 2026	Barclays	Glen Santangelo	PT Cut	Overweight	$850→$800
Feb 3, 2026	UBS	Andrea Alfonso	PT Cut	Neutral	$750→$730
Feb 3, 2026	BTIG	Mark Massaro	PT Cut	Buy	$830→$800
Dec 9, 2025	Barclays	Glen Santangelo	Initiate	Overweight	$850
Nov 4, 2025	Morgan Stanley	Erin Wright	PT Raise	Overweight	$765→$805
Nov 4, 2025	UBS	Andrea Alfonso	PT Raise	Neutral	$710→$750